Estimation of hereditary fructose intolerance prevalence in the Chinese population

Abstract Background Hereditary fructose intolerance (HFI) caused by aldolase B reduction or deficiency that results in fructose metabolism disorder. The disease prevalence in the Chinese population is unknown, which impedes the formulation of HFI screening and diagnosis strategies. Materials and met...

Full description

Bibliographic Details
Main Authors: Meiling Tang, Xiang Chen, Qi Ni, Yulan Lu, Bingbing Wu, Huijun Wang, Zhaoqing Yin, Wenhao Zhou, Xinran Dong
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-022-02487-3
_version_ 1811285849799655424
author Meiling Tang
Xiang Chen
Qi Ni
Yulan Lu
Bingbing Wu
Huijun Wang
Zhaoqing Yin
Wenhao Zhou
Xinran Dong
author_facet Meiling Tang
Xiang Chen
Qi Ni
Yulan Lu
Bingbing Wu
Huijun Wang
Zhaoqing Yin
Wenhao Zhou
Xinran Dong
author_sort Meiling Tang
collection DOAJ
description Abstract Background Hereditary fructose intolerance (HFI) caused by aldolase B reduction or deficiency that results in fructose metabolism disorder. The disease prevalence in the Chinese population is unknown, which impedes the formulation of HFI screening and diagnosis strategies. Materials and methods By searching a local cohort (Chinese Children’s Rare Disease Genetic Testing Clinical Collaboration System, CCGT) and public databases (ClinVar and Human Gene Mutation Database) and reviewing HFI-related literature, we manually curated ALDOB pathogenic or likely pathogenic (P/LP) variants according to ACMG guidelines. Allele frequency (AF) information from the local database CCGT and the public databases HuaBiao and gnomAD for ALDOB P/LP variants was used to estimate and the HFI prevalence in the Chinese population and other populations by the Bayesian framework. We collected the genotype and clinical characteristics of HFI patients from the CCGT database and published literature to study genotype–phenotype relationships. Result In total, 81 variants of ALDOB were curated as P/LP. The estimated Chinese HFI prevalence was approximately 1/504,678, which was much lower than that for non-Finland European (1/23,147), Finnish in Finland (1/55,539), admixed American (1/132,801) and Ashkenazi Jewish (1/263,150) populations. By analyzing the genetic characteristics of ALDOB in the Chinese population, two variants (A338V, A338G) had significantly higher AFs in the Chinese population than in the non-Finland European population from gnomAD (all P values < 0.05). Five variants (A150P, A175D, N335K, R60*, R304Q) had significantly lower AFs (all P values < 0.1). The genotype–phenotype association analyses were based on 68 reported HFI patients from a literature review and the CCGT database. The results showed that patients carrying homozygous variant sites (especially A150P) were more likely to present nausea, and patients carrying two missense variant sites were more likely to present aversion to sweets and fruit (all P values < 0.05). Our research reveals that some gastrointestinal symptoms seem to be associated with certain genotypes. Conclusion The prevalence of HFI in the Chinese population is extremely low, and there is no need to add HFI testing to the current newborn screening programs if medical costs are considered. A genetic testing strategy is suggested for early diagnosis of HFI.
first_indexed 2024-04-13T02:50:07Z
format Article
id doaj.art-10f52f9b8d5d4ff49a79d3321f7bc9b7
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-04-13T02:50:07Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-10f52f9b8d5d4ff49a79d3321f7bc9b72022-12-22T03:05:51ZengBMCOrphanet Journal of Rare Diseases1750-11722022-08-0117111010.1186/s13023-022-02487-3Estimation of hereditary fructose intolerance prevalence in the Chinese populationMeiling Tang0Xiang Chen1Qi Ni2Yulan Lu3Bingbing Wu4Huijun Wang5Zhaoqing Yin6Wenhao Zhou7Xinran Dong8Center for Molecular Medicine, Children’s Hospital of Fudan UniversityDepartment of Neonatology, Children’s Hospital of Fudan UniversityCenter for Molecular Medicine, Children’s Hospital of Fudan UniversityCenter for Molecular Medicine, Children’s Hospital of Fudan UniversityCenter for Molecular Medicine, Children’s Hospital of Fudan UniversityCenter for Molecular Medicine, Children’s Hospital of Fudan UniversityDepartment of Pediatrics, Dehong Hospital of Kunming Medical UniversityDepartment of Neonatology, Children’s Hospital of Fudan UniversityCenter for Molecular Medicine, Children’s Hospital of Fudan UniversityAbstract Background Hereditary fructose intolerance (HFI) caused by aldolase B reduction or deficiency that results in fructose metabolism disorder. The disease prevalence in the Chinese population is unknown, which impedes the formulation of HFI screening and diagnosis strategies. Materials and methods By searching a local cohort (Chinese Children’s Rare Disease Genetic Testing Clinical Collaboration System, CCGT) and public databases (ClinVar and Human Gene Mutation Database) and reviewing HFI-related literature, we manually curated ALDOB pathogenic or likely pathogenic (P/LP) variants according to ACMG guidelines. Allele frequency (AF) information from the local database CCGT and the public databases HuaBiao and gnomAD for ALDOB P/LP variants was used to estimate and the HFI prevalence in the Chinese population and other populations by the Bayesian framework. We collected the genotype and clinical characteristics of HFI patients from the CCGT database and published literature to study genotype–phenotype relationships. Result In total, 81 variants of ALDOB were curated as P/LP. The estimated Chinese HFI prevalence was approximately 1/504,678, which was much lower than that for non-Finland European (1/23,147), Finnish in Finland (1/55,539), admixed American (1/132,801) and Ashkenazi Jewish (1/263,150) populations. By analyzing the genetic characteristics of ALDOB in the Chinese population, two variants (A338V, A338G) had significantly higher AFs in the Chinese population than in the non-Finland European population from gnomAD (all P values < 0.05). Five variants (A150P, A175D, N335K, R60*, R304Q) had significantly lower AFs (all P values < 0.1). The genotype–phenotype association analyses were based on 68 reported HFI patients from a literature review and the CCGT database. The results showed that patients carrying homozygous variant sites (especially A150P) were more likely to present nausea, and patients carrying two missense variant sites were more likely to present aversion to sweets and fruit (all P values < 0.05). Our research reveals that some gastrointestinal symptoms seem to be associated with certain genotypes. Conclusion The prevalence of HFI in the Chinese population is extremely low, and there is no need to add HFI testing to the current newborn screening programs if medical costs are considered. A genetic testing strategy is suggested for early diagnosis of HFI.https://doi.org/10.1186/s13023-022-02487-3Hereditary fructose intolerancePrevalence estimationCuration for pathogenic variantsNewborn screeningAllele frequency comparison
spellingShingle Meiling Tang
Xiang Chen
Qi Ni
Yulan Lu
Bingbing Wu
Huijun Wang
Zhaoqing Yin
Wenhao Zhou
Xinran Dong
Estimation of hereditary fructose intolerance prevalence in the Chinese population
Orphanet Journal of Rare Diseases
Hereditary fructose intolerance
Prevalence estimation
Curation for pathogenic variants
Newborn screening
Allele frequency comparison
title Estimation of hereditary fructose intolerance prevalence in the Chinese population
title_full Estimation of hereditary fructose intolerance prevalence in the Chinese population
title_fullStr Estimation of hereditary fructose intolerance prevalence in the Chinese population
title_full_unstemmed Estimation of hereditary fructose intolerance prevalence in the Chinese population
title_short Estimation of hereditary fructose intolerance prevalence in the Chinese population
title_sort estimation of hereditary fructose intolerance prevalence in the chinese population
topic Hereditary fructose intolerance
Prevalence estimation
Curation for pathogenic variants
Newborn screening
Allele frequency comparison
url https://doi.org/10.1186/s13023-022-02487-3
work_keys_str_mv AT meilingtang estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT xiangchen estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT qini estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT yulanlu estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT bingbingwu estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT huijunwang estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT zhaoqingyin estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT wenhaozhou estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation
AT xinrandong estimationofhereditaryfructoseintoleranceprevalenceinthechinesepopulation